Development new radiopharmaceutical based on 5-thio-d- glucose labeled technetium-99m; IOP Conference Series: Materials Science and Engineering; Vol. 135 : Issues of Physics and Technology in Science, Industry and Medicine

Detalhes bibliográficos
Parent link:IOP Conference Series: Materials Science and Engineering
Vol. 135 : Issues of Physics and Technology in Science, Industry and Medicine.— 2016.— [012044, 6 p.]
Autor Corporativo: Национальный исследовательский Томский политехнический университет (ТПУ) Физико-технический институт (ФТИ) Лаборатория № 31 ядерного реактора (Лаборатория № 31 ЯР)
Outros Autores: Stasyuk (Stasiuk) E. S. Elena Sergeyevna, Skuridin V. S. Viktor Sergeyevich, Ilina E. S. Elena Sergeevna, Rogov A. S. Alexander Sergeyevich, Nesterov E. A. Evgeny Alexandrovich, Sadkin V. L. Vladimir Leonidovich, Larionova L. A. Lyudmila Aleksandrovna, Varlamova N. V. Natalya Valeryevna, Zelchan (Zeltchan) R. V. Roman Vladimirovich
Resumo:Title screen
The article considers the obtaining and possibility of using 5-thio-D-glucose labeled technetium-99m for the diagnosis of malignant tumors by single photon emission computed tomography. The analysis of the level of international developments of radiopharmaceuticals based on derivatives of glucose has been carried out. Also the article provides information on of using experimental batches of lyophilisate on the basis of 5-thio-D-glucose for preliminary biomedical testing on the mice.
Idioma:inglês
Publicado em: 2016
Assuntos:
Acesso em linha:http://dx.doi.org/10.1088/1757-899X/135/1/012044
http://earchive.tpu.ru/handle/11683/34834
Formato: Recurso Electrónico Capítulo de Livro
KOHA link:https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=650330